Millennium Pharmacon International Market Cap ($13.66 Million)
Market Cap & Net Worth: Millennium Pharmacon International (SDPC)
Millennium Pharmacon International market cap. Millennium Pharmacon International (JK:SDPC) has a market capitalization of $13.66 Million (Rp233.14 Billion) as of November 7, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #26077 globally and #561 in its home market, demonstrating a -7.58% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Millennium Pharmacon International's stock price Rp183.00 by its total outstanding shares 1274000000 (1.27 Billion). Also see cash efficiency ratio of Millennium Pharmacon International for how efficiently the company converts equity into cash flow.
Millennium Pharmacon International Market Cap History (2015–2026)
Millennium Pharmacon International market cap history from 2015 to 2026. Data shows growth from $4.36 Million to $13.66 Million (11.03% CAGR). Check SDPC stock price and chart for real-time trading data and today's change.
Index Memberships
Millennium Pharmacon International is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Jakarta Stock Exchange Composite Index
JKSE
|
$405.73 Billion | 0.00% | #549 of 864 |
Weight: Millennium Pharmacon International's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Millennium Pharmacon International Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Millennium Pharmacon International's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Millennium Pharmacon International to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Millennium Pharmacon International's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Millennium Pharmacon International's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $4.36 Million | $1.71 Trillion | $11.91 Billion | 0.00x | 0.00x |
| 2016 | $6.15 Million | $1.97 Trillion | $11.11 Billion | 0.00x | 0.00x |
| 2017 | $7.44 Million | $2.11 Trillion | $14.18 Billion | 0.00x | 0.00x |
| 2018 | $6.55 Million | $2.38 Trillion | $19.44 Billion | 0.00x | 0.00x |
| 2019 | $6.73 Million | $2.73 Trillion | $7.88 Billion | 0.00x | 0.00x |
| 2020 | $7.42 Million | $2.64 Trillion | $2.80 Billion | 0.00x | 0.00x |
| 2021 | $9.74 Million | $2.99 Trillion | $9.57 Billion | 0.00x | 0.00x |
| 2022 | $23.96 Million | $3.20 Trillion | $24.46 Billion | 0.00x | 0.00x |
| 2023 | $11.57 Million | $3.36 Trillion | $33.09 Billion | 0.00x | 0.00x |
| 2024 | $9.85 Million | $3.92 Trillion | $16.91 Billion | 0.00x | 0.00x |
Competitor Companies of SDPC by Market Capitalization
Companies near Millennium Pharmacon International in the global market cap rankings as of November 7, 2026. Also see SDPC total assets for a full breakdown of the balance sheet.
Key companies related to Millennium Pharmacon International by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #245 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #446 globally with a market cap of $61.32 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #616 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1118 globally with a market cap of $23.03 Billion USD ( AU$32.55 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #245 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $1060.84 |
| #446 | Cencora Inc. | NYSE:COR | $61.32 Billion | $333.56 |
| #616 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $271.72 |
| #1118 | Sigma Healthcare Ltd | AU:SIG | $23.03 Billion | AU$2.82 |
Market Capitalization of Millennium Pharmacon International (2015–2026)
Market capitalization of Millennium Pharmacon International from 2015 to today. Between 2015 and today, Millennium Pharmacon International's market cap moved from $4.36 Million to $ 13.66 Million, with a yearly change of 11.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp13.66 Million | +18.06% |
| 2025 | Rp11.57 Million | +17.42% |
| 2024 | Rp9.85 Million | -14.84% |
| 2023 | Rp11.57 Million | -51.70% |
| 2022 | Rp23.96 Million | +145.98% |
| 2021 | Rp9.74 Million | +31.27% |
| 2020 | Rp7.42 Million | +10.23% |
| 2019 | Rp6.73 Million | +2.78% |
| 2018 | Rp6.55 Million | -11.94% |
| 2017 | Rp7.44 Million | +20.91% |
| 2016 | Rp6.15 Million | +41.10% |
| 2015 | Rp4.36 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Millennium Pharmacon International was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.66 Million USD |
| MoneyControl | $13.66 Million USD |
| MarketWatch | $13.66 Million USD |
| marketcap.company | $13.66 Million USD |
| Reuters | $13.66 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Millennium Pharmacon International
PT Millennium Pharmacon International Tbk engages in the distribution of prescription and non-prescription medicines and medical devices in Indonesia. The company was formerly known as PT NVPD Soedarpo Corporation Tbk and changed its name to PT Millennium Pharmacon International Tbk in February 1990. The company was founded in 1952 and is headquartered in Jakarta Selatan, Indonesia. PT Millennium… Read more